RECRUITING

Accuracy of the EvieMED Ring Pulse Oximeter in Profound Hypoxia

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this study was to evaluate the accuracy of pulse oximeters over the range of 70-100% per the International Organization for Standardization (ISO) 80601-2-61:2019. Four test devices were placed on each subject on the left or right hand with two at the finger base and two at the fingertip. Motion equipment was used to control motion of the test devices. In addition, two test devices were placed on the contralateral hand on the base of a finger and also on the fingertip. Finally, a test wrist device was placed on either the left or right wrist. SpO2 measurements from these devices were compared to sampling of arterial blood during brief stable oxygen desaturation in healthy volunteers to evaluate the claimed range.

Official Title

Accuracy of the Evie Ring Pulse Oximeter in Profound Hypoxia

Quick Facts

Study Start:2024-06-11
Study Completion:2024-06-13
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06459206

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 49 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Kim Tompkins
CONTACT
+1 (408) 981-488
ktompkins@movano.com

Principal Investigator

Philip Bickler, MD, PhD
PRINCIPAL_INVESTIGATOR
University of California at San Francisco (UCSF)

Study Locations (Sites)

Hypoxia Research Laboratory
San Francisco, California, 94133
United States

Collaborators and Investigators

Sponsor: Movano Health

  • Philip Bickler, MD, PhD, PRINCIPAL_INVESTIGATOR, University of California at San Francisco (UCSF)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-11
Study Completion Date2024-06-13

Study Record Updates

Study Start Date2024-06-11
Study Completion Date2024-06-13

Terms related to this study

Additional Relevant MeSH Terms

  • Hypoxia